Search research articles
Contact Us
Filters
Showing results (11-20 of 409) with videos related to
Page
of 41
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
July 14, 2004
Reporting the results of randomized clinical trials: a priority of Archives of Ophthalmology
Roy W Beck
Ophthalmology
|
May 3, 2006
Sample size for a clinical trial: why do some trials need only 100 patients and others 1000 patients or more?
Roy W Beck
Diabetes Technology & Therapeutics
|
March 27, 2023
The Association of Time in Range and Diabetic Complications: The Evidence Is Strong
Roy W Beck
The New England Journal of Medicine
|
February 26, 2015
Glycemic control and excess mortality in type 1 diabetes
Roy W Beck
American Journal of Ophthalmology
|
September 15, 2004
Photodynamic therapy for age-related macular degeneration
Roy W Beck
Diabetes Technology & Therapeutics
|
February 1, 2026
Use of Inhaled Insulin with Automated Insulin Delivery Systems
Eda Cengiz, Roy W Beck
JAMA Ophthalmology
|
August 23, 2019
Emphasizing Optimal Diabetes Management for All Races/Ethnicities, but Not Race/Ethnicity-Specific Cut Points for Hemoglobin A1c
Richard M Bergenstal, Roy W Beck
Lancet (London, England)
|
May 26, 2009
Continuous glucose monitoring in type 1 diabetes mellitus
William V Tamborlane, Roy W Beck
Diabetes Technology & Therapeutics
|
September 27, 2021
Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes?
Roy W Beck, Richard M Bergenstal
Diabetes Care
|
June 23, 2016
Design Considerations for Artificial Pancreas Pivotal Studies
Steven J Russell, Roy W Beck
Page
of 41
Search research articles
Search
Showing results (11-20 of 409) with videos related to
Sort By:
Page
of 41
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
July 14, 2004
Reporting the results of randomized clinical trials: a priority of Archives of Ophthalmology
Roy W Beck
Ophthalmology
|
May 3, 2006
Sample size for a clinical trial: why do some trials need only 100 patients and others 1000 patients or more?
Roy W Beck
Diabetes Technology & Therapeutics
|
March 27, 2023
The Association of Time in Range and Diabetic Complications: The Evidence Is Strong
Roy W Beck
The New England Journal of Medicine
|
February 26, 2015
Glycemic control and excess mortality in type 1 diabetes
Roy W Beck
American Journal of Ophthalmology
|
September 15, 2004
Photodynamic therapy for age-related macular degeneration
Roy W Beck
Diabetes Technology & Therapeutics
|
February 1, 2026
Use of Inhaled Insulin with Automated Insulin Delivery Systems
Eda Cengiz, Roy W Beck
JAMA Ophthalmology
|
August 23, 2019
Emphasizing Optimal Diabetes Management for All Races/Ethnicities, but Not Race/Ethnicity-Specific Cut Points for Hemoglobin A1c
Richard M Bergenstal, Roy W Beck
Lancet (London, England)
|
May 26, 2009
Continuous glucose monitoring in type 1 diabetes mellitus
William V Tamborlane, Roy W Beck
Diabetes Technology & Therapeutics
|
September 27, 2021
Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes?
Roy W Beck, Richard M Bergenstal
Diabetes Care
|
June 23, 2016
Design Considerations for Artificial Pancreas Pivotal Studies
Steven J Russell, Roy W Beck
Page
of 41